Locations:
Search IconSearch

Tag: alzheimer disease (AD)

22-NEU-3383669-CQD-Hero-650×450

Big Patient Data Analyses Pinpoint Telmisartan as a Candidate Drug for Alzheimer’s in Black Adults

Findings underscore need for racial diversity in ongoing and future trials

Older woman holding photo album
October 31, 2022/Neurosciences/Brain Health

Alzheimer’s Disease in Women: How Our Understanding Continues to Evolve

Investigative highlights include hormone therapies, biomarkers and early lifestyle interventions

21-NEU-2568466-CQD-Hero-2-650×450

Sildenafil Emerges as a Candidate Drug for Alzheimer’s Disease

69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies

21-NEU-2210808_COVID-19-neurologic-manifestations_650x450

Study Suggests Mechanistic Overlap Between Alzheimer’s and COVID-19

Links are centered on neuroinflammation and microvascular injury, network medicine study finds

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Stock image of genetic testing
May 27, 2021/Geriatrics

Clinical Diagnosis of Alzheimer’s Disease Depends on Both Clinical and Biomarker Evidence

Both are essential, say updated International Working Group recommendations

Patient on exercise bike
January 19, 2021/Geriatrics

CYCLE-AD Trial: High-Intensity Exercise to Stave Off Alzheimer’s Disease

New NIH-funded study tests home-based intervention in high-risk group

20-NEU-2024366_alzheimer-brain-pathology_650x450
December 9, 2020/Geriatrics

Emerging Blood-Based Biomarkers for Alzheimer Disease: A Status Report

A screening blood test would be a huge step toward earlier intervention

High-tech brain

AI-Based Cognitive Assessments Help Diagnose High-IQ Patient with Alzheimer Disease

Machine learning algorithm also screens for reversible causes of cognitive decline

20-NEU-1971409_welcome-to-Nevada_650x450
September 18, 2020/Geriatrics

Getting Serious About Curbing Rural Disparities in Dementia Care and Research

NIA grant helps establish Nevada exploratory Alzheimer’s Disease Research Center

20-NEU-1918414-alzheimer-brain-650×450

Studies of an Alpha-1 Adrenergic Agonist for Alzheimer’s Advance With New NIA Grant

$2 million will enable preclinical dose and efficacy testing of “compound 3”

BackPage 2 of 3Next

Advertisement

Ad